COMMUNIQUÉS West-GlobeNewswire

Nexstim Plc: Invitation to the Extraordinary General Meeting
31/10/2018
Company announcement, Helsinki, 31 October 2018 at 2:00 PM Nexstim Plc: Invitation to the Extraordinary General Meeting Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing and marketing [...]
Nuvectra® to Participate in Two Upcoming Investor Conferences
31/10/2018
PLANO, Texas, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief [...]
Study: Liberals and news junkies on edge as midterms approach
31/10/2018
Left-leaning politics, frequent news consumption tied to greater anxiety symptoms SAN FRANCISCO, Oct. 31, 2018 (GLOBE NEWSWIRE) -- With the midterm elections less than a week away, anxiety in America is running high. [...]
CASMED Reports Third-Quarter 2018 Financial Results
31/10/2018
FORE-SIGHT® sales increase 20%; sensor sales up 22% on 20% growth in the U.S.; operating loss narrows by 25% Conference Call Begins at 10:00 a.m. Eastern Time Today BRANFORD, Conn., Oct. 31, 2018 (GLOBE NEWSWIRE) -- CAS [...]
Chembio to Report Third Quarter 2018 Financial Results on November 8, 2018
31/10/2018
MEDFORD, N.Y., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will release financial [...]
Sun BioPharma, Inc. Announces Leadership Changes
31/10/2018
David B. Kaysen Steps Down as President, CEO and Board Member Effective October 31, 2018 Michael T. Cullen MD, MBA, Executive Chairman, Elected President and CEO by Board of Directors Effective October 31, 2018 [...]
Quotient Limited to Participate in the Jefferies 2018 London Healthcare Conference
31/10/2018
JERSEY, Channel Islands, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Quotient (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chief Financial Officer, Chris Lindop, will present at the [...]
HempAmericana Readies to Launch its Own Proprietary CBD Oil
31/10/2018
NEW YORK, Oct. 31, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- HempAmericana, Inc. (OTC: HMPQ) (“HempAmericana” or the “Company”) is excited to announce that the Company is about to take delivery of the final two pieces [...]
Anchiano Therapeutics Announces Confidential Submission of Draft Registration Statement for U.S. Initial Public Offering
31/10/2018
CAMBRIDGE, Mass., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Anchiano Therapeutics Ltd. (TASE: ANCN), a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat cancer, today [...]
Momenta Pharmaceuticals Announces Date of Third Quarter 2018 Financial Results Conference Call and Webcast
31/10/2018
CAMBRIDGE, Mass., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA), today announced that it will release its financial results for the third quarter ended September 30, 2018 and provide a [...]
Enzymatica AB: Breakthrough agreement for Japan and lower sales in Q3 due to restrictions in Germany
31/10/2018
Interim report for Enzymatica AB (publ) JANUARY-SEPTEMBER 2018 Breakthrough agreement for Japan and lower sales in Q3 due to restrictions in Germany Q3 Net sales reached SEK 13.2 (24.8) million. Net profit after tax [...]
Verona Pharma Completes Enrollment in Phase 2 Clinical Trial Evaluating Nebulized RPL554 as Add-on to Dual Bronchodilator Therapy for COPD Maintenance Treatment
31/10/2018
Enrollment complete ahead of schedule Top line data expected in January 2019 LONDON, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical [...]
Motif Bio to participate at upcoming Jefferies London Healthcare Conference
31/10/2018
NEW YORK, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM/NASDAQ: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, announced today that the Company will participate in [...]
Sanofi Q3 2018 Performance Confirms Return to Growth
31/10/2018
Paris, October 31, 2018 Sanofi Q3 2018 Performance Confirms Return to Growth Q3 2018 Change Change at CER 9M 2018 Change Change at CER IFRS net sales reported €9,392m +3.7% +6.3% €25,466m -3.5% +2.1% IFRS net income [...]
La performance de Sanofi au T3 2018 confirme son retour à la croissance
31/10/2018
Paris, le 31 octobre 2018 La performance de Sanofi au T3 2018 confirme son retour à la croissance T3 2018 Variation Variation à TCC 9M 2018 Variation Variation à TCC Chiffre d'affaires net IFRS publié €9 392m +3,7% +6,3 [...]
ObsEva SA to Hold Third Quarter 2018 Financial Results and Business Update Call on November 8, 2018
31/10/2018
Geneva, Switzerland and Boston, MA –October 31, 2018 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a Swiss clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for [...]
Medical patients’ access to Hydropothecary cannabis products remains a priority for HEXO Corp
30/10/2018
GATINEAU, Quebec, Oct. 30, 2018 (GLOBE NEWSWIRE) -- HEXO Corp has wasted no time in reassuring its current medical patients that it has safeguarded products and bandwidth to continue to deliver the quality, award- [...]
Accès des patients aux produits de cannabis Hydropothecary : toujours une priorité pour HEXO Corp
30/10/2018
GATINEAU, Québec,, 30 oct. 2018 (GLOBE NEWSWIRE) -- HEXO Corp s’empresse de rassurer les patients qui font actuellement partie de sa clientèle médicale : suffisamment de stocks de toute sa gamme ont été mis de côté pour [...]
ProQR obtient de Ionis Pharmaceuticals des droits mondiaux sous licence sur un médicament candidat en ophtalmologie
30/10/2018
ProQR reçoit une licence mondiale exclusive pour IONIS-RHO-2.5 Rx , désormais dénommé QR-1123, destiné au traitement de la rétinite pigmentaire autosomique dominante (adRP), une forme rare de cécité héréditaire sans [...]

Pages